Rifampicin resistance mutations in the 81 bp RRDR of rpoB gene in Mycobacterium tuberculosis clinical isolates using Xpert® MTB/RIF in Kampala, Uganda: A retrospective study

BMC Infectious Diseases

Volumn 14, Issue 1, 2014, Pages

  Mboowa, Gerald ^a   Namaganda, Carolyn ^a   Ssengooba, Willy ^a  

^a MAKERERE UNIVERSITY   (Uganda)

Author keywords

Multi drug Resistant tuberculosis; Rifampicin resistance determining region; RNA polymerase B gene; Xpert MTB RIF

Indexed keywords

RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; BACTERIAL PROTEIN; DIAGNOSTIC KIT; RPOB PROTEIN, MYCOBACTERIUM TUBERCULOSIS;

AGAR MEDIUM; ANTIBIOTIC RESISTANCE; ARTICLE; ASSAY; BACTERIUM DETECTION; BACTERIUM ISOLATE; CODON; CONTROLLED STUDY; GENE MUTATION; HUMAN; INTERMETHOD COMPARISON; MTB RIF ASSAY; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; RETROSPECTIVE STUDY; RPOB GENE; UGANDA; DIAGNOSTIC KIT; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MUTATION; TUBERCULOSIS, MULTIDRUG-RESISTANT;

BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; HUMANS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; RETROSPECTIVE STUDIES; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT; UGANDA;

EID: 84907024909     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-14-481     Document Type: Article

References (16)

1. Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, Safi H, Blakemore R, Lan NT, Jones-Lo´pez EC, Levi M, Burday M, Ayakaka I, Mugerwa RD, McMillan B, Winn-Deen E, Christel L, Dailey P, Perkins MD, Persing DH, Alland D. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 2010, 48:229-37. 10.1128/JCM.01463-09, 2812290, 19864480.
2. Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodriques C, Alland D, Perkins MD. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010, 363:1005-15. 10.1056/NEJMoa0907847, 2947799, 20825313.
3. Ramaswamy S, Musser JM. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis. Tuberc Lung Dis 1998, 79:3-29.
4. Drobniewski FA, Wilson SM. The rapid diagnosis of isoniazid and rifampin resistance in Mycobacterium tuberculosis: a molecular story. J. Med. Microbiol 1998, 47:189-96. 10.1099/00222615-47-3-189, 9511823.
5. Global tuberculosis Report 2013, https://extranet.who.int/sree/Reports?op=Replet&name=/WHO_HQ_Reports/G2/PROD/EXT/TBCountryProfile&ISO2=UG&outtype=html, Global tuberculosis Report.
6. Li WM, Wang SM, Li CY, Liu YH, Shen GM, Zhang XX, Niu TG, Gao Q, van Soolingen D, Kremer K, Duanmu HJ. Molecular epidemiology of Mycobacterium tuberculosis in China: a nationwide random survey in 2000. Int J Tuberc Lung Dis 2005, 9(12):1314-19.
7. Mokrousov I, Bhanu NV, Suffys PN, Kadival GV, Yap SF, Cho SN, Jordaan AM, Narvskaya O, Singh UB, Gomes HM, Lee H, Kulkarni SP, Lim KC, Khan BK, van Soolingen D, Victor TC, Schouls LM. Multicenter evaluation 325 of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. J Microbiol Methods 2004, 57(3):323-35. 10.1016/j.mimet.2004.02.006, 15134881.
8. Tsolaki AG, Gagneux S, Pym AS, de la Salmoniere YO G, Kreiswirth BN, Van Soolingen D, Small PM. Genomic deletions classify the Beijing/W strains as a distinct genetic lineage of Mycobacterium tuberculosis. J Clin Microbiol 2005, 43(7):3185-91. 10.1128/JCM.43.7.3185-3191.2005, 1169157, 16000433.
9. van Soolingen D, Qian L, de Haas PE, Douglas JT, Traore H, Portaels F, Qing HZ, Enkhsaikan D, Nymadawa P, van Embden JD. Predominance of a single genotype of Mycobacterium tuberculosis in countries of East Asia. J Clin Microbiol 1995, 33(12):3234-38. 228679, 8586708.
10. Brossier F, Veziris N, Truffot-Pernot C, Jarlier V, Sougakoff W. Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low-and high-level resistance. J Clin Microbiol 2006, 44(11 Pt 2):3659-64. 1594786, 17021094.
11. Ocheretina O, Escuyer VE, Mabou M, Royal-Mardi G, Collins S, Vilbrun SC, Pape JW, Fitzgerald DW. Correlation between Genotypic and Phenotypic Testing for Resistance to Rifampin in Mycobacterium tuberculosis Clinical Isolates in Haiti: Investigation of Cases with Discrepant Susceptibility Results. PLoS ONE 2014, 9(3):e90569. 10.1371/journal.pone.0090569, 3944071, 24599230.
12. Jones-Lo´pez E, Manabe YC, Palaci M, Kayiza C, Armstrong D, Nakiyingi L, Ssengooba W, Gaeddert M, Kubiak R, Almeida JP, Alland D, Dietze R, Joloba LM, Ellner JJ, Dorman SE. Prospective cross-sectional evaluation of the small membrane filtration method for diagnosis of pulmonary tuberculosis. J Clin Microbiol 2014, 52(7):2513-20. 10.1128/JCM.00642-14, 24808236.
13. Yue J, Shi W, Xie J, Li Y, Zeng E. Mutations in the rpoB Gene of Multidrug-Resistant Mycobacterium tuberculosis Isolates from China. J Clin Microbiol 2003, 41(5):2209-12. 10.1128/JCM.41.5.2209-2212.2003, 154692, 12734282.
14. Moure R, Muñoz L, Torres M, Santin M, Marti´n R, Alcaide F. Rapid detection of Mycobacterium tuberculosis complex and rifampin resistance in smear-negative clinical samples by use of an integrated real time PCR method. J Clin Microbiol 2011, 49:1137-39. 10.1128/JCM.01831-10, 3067676, 21191053.
15. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD. Feasibility, diagnostic accuracy and effectiveness of decentralised use of the Xpert® MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011, 377:1495-05. 10.1016/S0140-6736(11)60438-8, 3085933, 21507477.
16. Lukoye D, Adatu F, Musisi K, Kasule GW, Were W, Odeke R, Kalamya JN, Awor A, Date A, Joloba LM. Anti-Tuberculosis Drug Resistance among New and Previously Treated Sputum Smear-Positive Tuberculosis Patients in Uganda: Results of the First National Survey. PLoS ONE 2013, 8(8):e70763. 10.1371/journal.pone.0070763, 3731251, 23936467.